Basit öğe kaydını göster

dc.contributor.authorGulcelik, Mehmet Ali
dc.contributor.authorColakoglu, Kadri
dc.contributor.authorDincer, Halil
dc.contributor.authorDogan, Lutfi
dc.contributor.authorYenidogan, Erdinc
dc.contributor.authorGulcelik, Nese Ersoz
dc.date.accessioned2019-12-10T11:10:25Z
dc.date.available2019-12-10T11:10:25Z
dc.date.issued2012
dc.identifier.issn1513-7368
dc.identifier.urihttps://doi.org/10.7314/APJCP.2012.13.1.395
dc.identifier.urihttp://hdl.handle.net/11655/14856
dc.description.abstractObjectives: Breast and colon cancer are neoplasms well known to be related to obesity. Adiponectin, a protein that increases in obesity, seems to be involved in the relationship but clinical data are limited. Methods: In this study, we therefore evaluated the serum adiponectin levels in 87 breast and 27 colon cancer patients and assessed the relation with BMI, menopausal status, receptor status and stage of disease. Results: Serum adiponectin levels were lower in cancer cases (8583 +/- 2095 ng/ml for breast cancer, 9513 +/- 2276 for colon cancer) than in controls (13905 +/- 3263). Conclusion: A low serum adiponectin level may be associated with both breast and colon cancer, and that this association is not statistically significant for either receptor or menopausal status in breast cancer groups.
dc.language.isoen
dc.publisherAsian Pacific Organization Cancer Prevention
dc.relation.isversionof10.7314/APJCP.2012.13.1.395
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectOncology
dc.titleAssociations Between Adiponectin and Two Different Cancers: Breast and Colon
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAsian Pacific Journal Of Cancer Prevention
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume13
dc.identifier.issue1
dc.identifier.startpage395
dc.identifier.endpage398
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster